Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $224.18 Billion |
|---|---|
| Enterprise Value | $759.11 Billion |
| Annual dividend | $0.20 |
| Dividend yield | 2.26% |
| Earnings per Share | $- |
| Beta | -0.61 |
| Outstanding Shares | - |
| P/E Ratio | 20.77 |
|---|---|
| PEG | -16.91 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.11 |
| Enterprise Value to EBIT | 20.6 |
| Enterprise Value to Net Income | 70 |
| Total Debt to Enterprise | 0.87 |
| Debt to Equity | 2.11 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Nipro Corporation, along with its affiliated companies, operates across three primary business divisions: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device sector is dedicated to the development...